Editor, Scrip & Pink Sheet, covering pharmaceutical and business news and analysis; views expressed are purely my own.

Read Full Bio →


Eleanor has been Editor of Scrip Intelligence since 2014. She has worked on the title since 2000, reporting and analysing all aspects of the global pharma industry from M&A and partnering, financial and strategy news and trends through R&D to market access, policy and regulation. She has ...